Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa M Alvarez

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 22, 2007
4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as non-peptidic selective delta-opioid agonists with potential anxiolytic/antidepressant properties. Part 2Andrés A Trabanco, Nancy Aerts, Rosa M Alvarez, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha(2)-adrenoceptor antagonistic activities: a novel series of potential antidepressantsJ Ignacio Andrés, Jesús Alcázar, José M Alonso, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonistsAndrés A Trabanco, Shirley Pullan, José M Alonso, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha2-adrenoceptor antagonistic activities. Part 2: Further exploration on the cinnamyl moietyJoaquín Pastor, Jesús Alcázar, Rosa M Alvarez, et al.
European Journal of Medicinal Chemistry|July 20, 2021
Corrigendum to <' Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors' [Eur. J. Med. Chem. 211 (2021), 113109]Rosa M Alvarez, Ana Belén García, Concepción Riesco-Fagundo, et al.
Cancer Research Communications|July 25, 2022
Influence of germline <i>BRCA</i> genotype on the survival of patients with triple-negative breast cancerCynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
Bioorganic & Medicinal Chemistry|April 5, 2007
Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonismJ Ignacio Andrés, Jesús Alcázar, José M Alonso, et al.
Salud Publica De Mexico|April 19, 2022
Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancerYanin Chavarri-Guerra, Cynthia Villarreal-Garza, Ana S Ferrigno, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activityJ Ignacio Andrés, Jesús Alcázar, José M Alonso, et al.
Ebiomedicine|April 13, 2019
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegalyMiguel Chenlo, Iria A Rodriguez-Gomez, Ramon Serramito, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|May 22, 2007
4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as non-peptidic selective delta-opioid agonists with potential anxiolytic/antidepressant properties. Part 2Andrés A Trabanco, Nancy Aerts, Rosa M Alvarez, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha(2)-adrenoceptor antagonistic activities: a novel series of potential antidepressantsJ Ignacio Andrés, Jesús Alcázar, José M Alonso, et al.
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonistsAndrés A Trabanco, Shirley Pullan, José M Alonso, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha2-adrenoceptor antagonistic activities. Part 2: Further exploration on the cinnamyl moietyJoaquín Pastor, Jesús Alcázar, Rosa M Alvarez, et al.
European Journal of Medicinal Chemistry|July 20, 2021
Corrigendum to <' Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors' [Eur. J. Med. Chem. 211 (2021), 113109]Rosa M Alvarez, Ana Belén García, Concepción Riesco-Fagundo, et al.
Cancer Research Communications|July 25, 2022
Influence of germline <i>BRCA</i> genotype on the survival of patients with triple-negative breast cancerCynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
Bioorganic & Medicinal Chemistry|April 5, 2007
Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonismJ Ignacio Andrés, Jesús Alcázar, José M Alonso, et al.
Salud Publica De Mexico|April 19, 2022
Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancerYanin Chavarri-Guerra, Cynthia Villarreal-Garza, Ana S Ferrigno, et al.
Journal of Medicinal Chemistry|March 18, 2005
Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activityJ Ignacio Andrés, Jesús Alcázar, José M Alonso, et al.
Ebiomedicine|April 13, 2019
Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegalyMiguel Chenlo, Iria A Rodriguez-Gomez, Ramon Serramito, et al.
Pageof 3